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Mechanisms by which oxygen regulates gene expression and cell-cell
interaction in the vasculature. Hypoxia has profound effects on blood
vessel tone. Acute hypoxia causes pulmonary vasoconstriction and chronic
hypoxia causes smooth muscle cell replication and extracellular matrix
accumulation resulting in vessel wall remodeling. The cellular responses to
hypoxia involve complex cell-cell interactions mediated by the release of
growth factors, eytokines and biological messengers. We have reported
that hypoxia increases the expression of a number of genes encoding
vascular cell mitogens produced by endothelial cells: platelet-derived
growth factor B (PDGF-B); endothelin-l (ET-I); and vascular endothelial
growth factor (VEOF). A 28-bp enhancer in the 5' upstream region of the
VEGF gene mediates the expression of VEGF by endothelial cells under
conditions of hypoxia. Hypoxia, however, has opposite effects on the
vasodilator nitric oxide (NO); hypoxia suppresses both the transcriptional
rate of the endothelial nitric oxide synthase gene and the stability of its
mRNA. These endothelial-dependent processes would lead to vessel wall
remodeling characteristic of a number of diseases from atherosclerosis to
pulmonary hypertension. The smooth muscle cell also responds to hyp-
oxia. It increases the transcriptional rate of the heme oxygenase gene-i
responsible for the breakdown of heme to carbon monoxide (CO) and
biliverdin. CO is a vasodilator with properties similar to the well-studied
molecule NO. CO suppresses the production of ET-1 and PDGF-B by
endothelial cells. The regulated production of NO and CO under hypoxia,
therefore, results in complex feedback loop interactions leading to altered
smooth muscle cell growth in an autoerine and paracrine manner.
Hypoxia is an important regulator of vascular tone. Acute
hypoxia in the lung causes arteriolar vasoconstriction with a rapid
rise in pulmonary vascular resistance. Chronic hypoxia results in
smooth muscle cell hyperplasia and extracellular matrix deposi-
tion. The mechanisms by which hypoxia causes these cellular and
matrix changes in the vessel wall involve complex cell-cell inter-
actions mediated by the release of growth factors, basement
membrane components, cytokines as well as biological messen-
gers.
Endothelial-derived nitric oxide (NO) maintains normal resting
blood vessel tone via cGMP-dependent and independent mecha-
nisms. It raises smooth muscle cell cGMP content resulting in
smooth muscle cell relaxation. Under hypoxia, however, when NO
production is suppressed [1], blood vessel tone is maintained by
the net balance of vasoconstrictors and dilators that are induced
by hypoxia and serve to modulate endothelial-vascular smooth
muscle cell (VSMC) interactions, leading to a number of vascular
phenomena from pulmonary hypertension to angiogenesis.
Like NO, carbon monoxide (CO) is an endogenously produced
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gas molecule that activates guanylyl cyclase [2, 31. Although a role
for CO has been suggested in neuronal signal transduction [4j,
increasing evidence implicates CO to also play a physiologic role
in the vasculature.
CO is produced from the breakdown of heme to biliverdin by
heme oxygenase (HO) [5]. Two isoforms of HO have been
identified: HO-i and HO-2 [6—8]. HO-i is inducible by a variety
of agents and HO-2 is constitutively expressed. The CO generated
from the activity of HO could, therefore, elevate cGMP levels in
the same or neighboring cells and regulate vascular tone in a
manner similar to NO. Furthermore, exogenous CO has been
shown to counteract the stimulating effects of hypoxia on the
transcription of a number of genes including erythropoietin (Epo)
[9], endothelin-1 (ET-i), platelet-derived growth factor-B (PDGF-B)
[iOj and vascular endothelial growth factor (VEGF) [Iii. Local
release of CO under physiologic or pathophysiologic conditions
would then be expected to modulate blood vessel function via
both a cGMP-dependent pathway as well as through the release of
such vascular mediators as ET-1 and PDGF-B. This report
summarizes recent work from our laboratory that suggests an
important physiologic role for VSMC-derived CO as a regulator
of gene expression, cell-cell interaction, and vascular cell prolif-
eration in the setting of hypoxia.
Methods
Cell culture
Primary cultures of human umbilical vein endothelial cells
(HUVEC), bovine pulmonary artery (BPAEC) or aortic endothe-
hal cells, and rat aortic and pulmonary artery smooth muscle cells
were exposed to low oxygen tensions in air tight chambers
(Billups-Rothenberg, Del Mar, CA, USA), flushed with preana-
lyzed low oxygen gas mixtures and kept at 37°C. The P02 in the
medium under hypoxic conditions was 18 to 20 mm Hg. Coculture
of endothelial and smooth muscle cells was performed using
Transwell plates (Costar Corp., Cambridge, MA, USA).
RNA analysis
Total cellular RNA was prepared by guanidinium isothiocya-
nate extraction from endothelial or smooth muscle cells after
hypoxic exposure for various periods. Total RNA (15 j.rgllane) was
separated by eleetrophoresis on 1% agarose gels containing
formaldehyde, transferred to membranes and hybridized with
radiolabeled probe (ET-i; PDGF-B; HO-1,2; -actin; nitric oxide
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Fig. 1. A positive hypoxia response element is present in the 5' flanking region of VEGF. Plasmids containing VEGF 5' flanking sequences fused to a
promoterless CAT gene were transfected into BPAEC, and CAT activity was determined. CAT activity was normalized to f3-galactosidase. Symbols are:
(LII) normoxia; (U) hypoxia.
synthase, as indicated in the legends). For quantification, autora-
diographs were scanned with a laser densitometer and relative
density differences were normalized to /3-actin.
cGMP accumulation
cGMP concentrations were determined in the presence of the
phosphodiesterase inhibitor, isobutylmethylxanthine (1 mM)
added to the media 20 minutes before obtaining cell extracts.
Cells were washed with ice-cold phosphate-buffered saline and
solubilized with 60% ethanol and centrifuged at 2000 >< g for 15
minutes. Supernatants were dried completely in 60°C vacuum
oven and cGMP concentration determined by radioimmunoassay
(Amersham Corp.) according to the manufacturer's instructions.
Nuclear run-on analysis
Nuclei were isolated from confluent cultures of cells and in vitro
transcription was performed as previously described [121. Hybrid-
ization to denatured probes was performed at 40°C for four days
in the presence of 50% formamide.
Transfection and CAT assays
Transfections of bovine pulmonary artery endothelial cells were
carried out with LipofectAmine (GIBCO-BRL) according to the
manufacturer's instructions. After transfection, cells were placed
in either normoxia or hypoxia for 24 or 48 hours, cells were lysed,
and /3-galactosidase and CAT activity were measured according to
previously-described protocols [13].
Nuclear extract preparation and EMSAs
Cell nuclear extracts were prepared according to the method of
Schreiber et al [14], and total protein was quantified by using the
Bio-Rad protein assay with bovine serum albumin as a standard.
For EMSA, 5 jig of nuclear proteins were incubated with the
appropriate radiolabeled probe as described [15] and the binding
mixture fractionated on a 4% polyactylamide gel in 0.5X TBE.
The gel was dried and autoradiography was performed at —80°C.
Results and discussion
To examine the cellular responses to hypoxia, we exposed
endothelial cells derived from various vascular beds (umbilical
vein, pulmonary artery, saphenous vein, etc.) to hypoxia and
examined the expression of a number of genes encoding vasoac-
tive mediators. We found that the steady-state mRNA levels of
PDGF-B were dramatically increased upon exposure to hypoxia at
24, 48 and 72 hours [12]. This effect of hypoxia was sustained with
more prolonged exposure and was entirely due to increases in the
transcriptional rate of the gene, as demonstrated by nuclear
run-on analysis. In addition to PDGF-B, the expression of the
ET-1 gene was also dramatically induced by hypoxia to a similar
degree. The increase in ET-1 occurred at a less severe degree of
hypoxia and at an earlier time point (within 1 hr of hypoxia vs. 12
hr for PDGF-B) [16]. This increase in ET-1 mRNA and transcrip-
tional rate resulted in corresponding increases in the endothelin
peptide detected in the conditioned media of the hypoxic endo-
thelial cells. Four- to sixfold increases in endothelin peptide were
detected within six hours of hypoxia and these differences per-
sisted at 24 hours.
In addition to PDGF-B and ET-1, VEGF was reported to be
dramatically induced by hypoxia in myoblasts [17]. It is commonly
thought that endothelial cells do not express VEGF, rather, they
are the target of VEGF action in the process of endothelial cell
proliferation leading to angiogenesis. Indeed, we were unable to
detect VEGF mRNA levels under normoxic conditions; however,
upon exposure of bovine pulmonary artery endothelial cells to
hypoxia, VEGF mRNA levels were dramatically induced [15].
To examine whether the increases in VEGF mRNA in endo-
thelial cells are regulated at the transcriptional level, we con-
structed a plasmid in which the promoter of the human VEGF
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gene was fused to the reporter chloramphenicol acetyltransferase
(CAT) gene by replacing the TK promoter in plasmid pBLCAT2
with that of VEGF (Fig. 1). The resulting plasmid pVR47ICAT
contains VEGF sequences from —2362 to +61 (relative to the
transcription initiation site). This plasmid was then transfected
into BPAE cells which were incubated under either hypoxic or
normoxic conditions. Plasmid pRSV-13-gal containing the 3-galac-
tosidase gene under the control of the Rous sarcoma virus long
terminal repeat was co-transfected into BPAE cells. Following
incubation, cells were lysed and CAT activity was measured and
normalized to that of J3-galactosidase. As shown in Figure 1, CAT
activity was induced 5.5-fold by hypoxia. These results indicate the
presence of a positive hypoxia response element in the 5' region
of the VEGF gene that regulates its transcription.
A series of deletions were made upstream of the transcription
initiation site in the plasmid pVR47/CAT. These new plasmids
were transfected into BPAE cells and CAT activity was deter-
mined. Hypoxia inducibility was retained until the deletions were
extended to —795. Further deletions resulted in loss of a hypoxic
response, however, the basal activity was retained and was similar
in all constructs. We postulated that the hypoxia response element
may reside in this 190 bp fragment. Indeed, when this 190 bp
fragment (—985 to —790) was excised from the surrounding
sequence and inserted in front of the TK promoter in plasmid
pBLCAT2, it provided a strong (8.4-fold) induction on CAT gene
expression [15].
Further localization of this element was carried out by ampli-
fying different segments within the 190 bp region by PCR and
testing their ability to increase CAT gene expression in response
to hypoxia. The smallest region which still provides hypoxia
inducibility (4.7-fold) is a 28 bp fragment (—978 to —951) close to
the 5' end of the 190 bp sequence. To investigate whether the
hypoxia regulatory element has the characteristics of a classic
enhancer, we inserted the above 28 bp fragment into the BamHI
site upstream of the TK promoter in pBLCAT2 in both orienta-
tions. The resulting plasmids both showed an 4.7-fold induction by
hypoxia. We have also inserted a second fragment (—985 to —863)
in either orientation downstream of the CAT gene and obtained
similar results, demonstrating that the hypoxia response element
is an enhancer.
Studies by Semenza et al [181 have shown that the HIF-1
recognition sequence contained in the hypoxia response element
of the erythropoietin (Epo) gene is conserved in a number of
glycolytic enzyme genes that are hypoxia-inducible. The consensus
in these elements is (G/CIT)ACGTGC(G/T) (Fig. 2). In sequence
comparison analysis, e have found a short region (underlined in
Fig. 2) in the VEGF hypoxia response element that is highly
Fig. 2. The cis elements 3' to the HIF-]
consensus are required for hypoxia response.
Deletions were made from either end of the
35-hp A-G fragment containing the VEGF
enhancer. These sequences are indicated in
bold and the substituted bases by either linker
or vector sequences are shown in lower case
letters. The nucleotides corresponding to the
HIF-1 binding consensus are underlined, and
the seventh nucleotide, which differs from the
consensus, is double underlined.
homologous to this consensus. The sequence of this region is
TACGTGGG and differs from the consensus in the seventh
nucleotide which is a G in the VEGF enhancer (double under-
lined), and a conserved C in the Epo and glycolytic enzyme genes.
We have made several deletions in the 35 bp fragment containing
the minimal 28 bp hypoxia response element and tested their
function in transfection experiments. The disruption of the core
HIF-1 binding sequence (construct V1714) eliminated hypoxia
inducibility. Interestingly, we found that the downstream se-
quence (3' to the core) is also important, because the replacement
of this region with linker or vector sequences without changing the
core either dramatically reduced the hypoxic induction (construct
V1316b) or abolished it completely (construct V1318). Therefore,
critical elements (TCCTCTF) in the region 3' to the consensus
are required for VEGF enhancer function.
An enhancer element exerts its function through the binding of
a trans-acting factor. To demonstrate the presence of such a
factor, we have radiolabeled fragment A-G (Fig. 2) and per-
formed in vitro binding followed by EMSA. A distinct band was
induced in nuclear extracts isolated from hypoxia-treated cells,
but not by normoxia-treated cells, which was competed by increas-
ing amounts (20-, 100-, and 500-fold excess) of unlabeled frag-
ment, but not by the same amounts of an arbitrary (an NFKB
binding sequence), indicating that the binding activity is specific
for the VEGF enhancer [151.
The only hypoxia-inducible factor that has been investigated so
far is the one that binds to the enhancer region of the Epo gene,
named HIF-1 [19—211. To explore potential common mechanisms
of transcriptional regulation by hypoxia between VEGF and Epo,
competition EMSA was carried out. A double-stranded oligonu-
cleotide competitor (W18) that is contained in the Epo enhancer
and has been shown to bind to HIF-1 could compete with labeled
VEGF enhancer for nuclear factors, although to a lesser extent
than the unlabeled enhancer, Thus, factors binding to the VEGF
enhancer may he related to, if not the same as, the component(s)
which hind to the Epo enhancer.
Interestingly, a 21-bp fragment, which retains an intact HIF-1
site but has a deletion of the sequence 3' to the consensus, allowed
for hypoxia-induced binding to occur in vitro. Since this fragment
does not have a function in the absence of the downstream
sequence, the binding of HIF-1 (or a similar factor) to the VEGF
enhancer is not sufficient to provide hypoxia inducibility.
Exposing endothelial cells to hypoxia therefore results in a
dramatic increase in the transcriptional rate of a number of genes
encoding vascular cell mitogens. However, the production of the
endothelia1derived dilator, NO, was suppressed by hypoxia. The
expression of the endothelial nitric oxide synthase (eNOS) gene
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Fig. 3. Effect of hypoxia on NO generation by endothelial cells. NO is
detected by measuring cGMP levels in smooth muscle cells co-cultured
with endothelial cells. Cell-associated cGMP levels are shown in smooth
muscle cells cultured alone (SMC A) or co-incubated with previously-
made hypoxic (H) or normoxic (N) endothelial cells. Columns are
means SEM, N = 6, < 0.001 versus normoxia (bar 1).
was suppressed by hypoxia and the half-life of its mRNA was
reduced from >24 hours to 12 hours [1] resulting in decreased
NOS activity and decreased accumulation of cGMP levels in
adjacent, cocultured smooth muscle cells (Fig. 3). Endothelial
cells were shown to increase smooth muscle cell cGMP content
four- to sixfold above the basal levels as previously reported [221.
However, when endothelial cells were previously made hypoxic,
they were no longer capable of stimulating a cGMP rise in
cocultured smooth muscle cells, and resulted in levels that were
comparable to those in smooth muscle cells cultured alone (Fig.
3). The basal content of cGMP is not due to NO production since
using inhibitors of NO synthesis did not reduce cUMP content
under either basal or hypoxic conditions.
NO is normally produced in the body and serves as an impor-
tant biological messenger not only for the regulation of vessel
tone, but also in neuronal transmission [23—251. Like NO, carbon
monoxide (CO) is an endogenously produced gas molecule that
activates guanylyl cyclase. There are at least two endogenous
sources of CO production, one of which is from the oxidation of
organic molecules, but the predominant source is from the
degradation of heme [261 via the enzyme HO. We designed
studies to determine whether CO could be produced by vascular
smooth muscle cells and investigated whether it could have a
physiological role in the regulation of cGMP levels in these cells
under both basal and hypoxic conditions.
Primary cultures of rat vascular smooth muscle cells (VSMC)
were exposed to hypoxic conditions for various periods of time
and the expression of HO-i was determined. There was a maximal
sevenfold rise in HO-i mRNA noted at 15 hours of hypoxia, but
by 48 hours, HO-I mRNA levels had returned to baseline despite
continued hypoxia [27]. In contrast, ET-1 and PDGF-B genes
previously shown to be induced by hypoxia, demonstrated a
sustained increase in their expression with prolonged hypoxic
exposure [12, 16]. HO-2 mRNA levels were unaffected by oxygen
in either endothelial or smooth muscle cells. Interestingly, we
found HO-I mRNA expression to be suppressed by hypoxia in
endothehal cells during the same time period while in coculture
with smooth muscle cells [28]. The regulation of HO-I by hypoxia
Fig. 5. VSMC suppress the hypoxia-induced increases in ET-] mRNA. Total
RNA was extracted from BPAEC exposed to hypoxia for 6 (lanes 2 and 6),
12 (lanes 3 and 7), 24 (lanes 4 and 8) and 48 hours (lanes 5 and 9). BPAEC
were cultured alone (lanes I to 5) or with VSMC (lanes 5 to 9). Relative
mRNA levels normalized to -actin and compared with time 0 control are
indicated.
is entirely due to increases in the transcriptional rate of the gene,
as the half-life of its mRNA is unaffected by hypoxia [271.
To determine whether the increased HO-i expression results in
increased CO release by VSMC, we developed a method to
measure CO in the media by adding hemoglobin (Hb) to the
cultures and quantifying HbCO spectrophotometrically [27]. Fig-
ure 4 shows the relative amounts of HbCO in media conditioned
by smooth muscle cells in the presence of endothelial cells and
compared to levels in media of endothelial cells cultured alone.
After hypoxie exposure for 12 hours, HbCO levels in the condi-
tioned media of VSMC cocultured with endothelial cells were
increased sevenfold above the levels in normoxic media and
declined to twofold by 48 hours of hypoxia. In contrast, endothe-
hal cells did not produce CO. Furthermore, this increase in CO
detected in the media correlated with corresponding increases in
cGMP accumulation in these cells. There was a peak in cGMP
levels within 15 to 24 hours of hypoxia, with a return to near
baseline levels by 48 hours [27]. Therefore, hypoxia is an impor-
tant physiologic regulator of VSMC cGMP levels. In this manner,
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Fig. 6. VSMC-denved CO inhibits the hypoxia-
induced expression of ET-1. Total RNA was
extracted from HUVEC exposed to normoxia
or hypoxia for 12 hours and Northern blot
analysis was performed. Lanes 1 to 5 indicate
normoxia, and lanes 6 to 12, hypoxia. Lanes 1
and 6 show ET-1 mRNA from HUVEC
cultured alone. Lanes 2 and 7 show FT-I
mRNA in HUVEC cocultured with VSMC.
Lanes 3 and 8 show HUVEC cocultured with
VSMC in the presence of SnPP-9 (1 mM). Lane
9 shows levels of ET-1 in the presence of lower
concentration of SnPP-9 (10 j.M). Lanes 4 and
10 show ET-1 mRNA in cocultured cells in the
presence of Hb (50 jLM) and I jM, respectively.
Cells were treated with L-NNA (2.5 mM) in
lanes 5 and 12.
VSMC-derived CO induced by hypoxia could regulate endothelial
cell permeability and barrier integrity in a paracrine fashion.
CO not only regulates cGMP levels, it can regulate gene
expression. Exogenous CO has been shown to suppress the
hypoxic induction of the erythropoietin 9}, ET-1 and PDGF-B
[10j, and VEGF genes [11]. We investigated whether CO at the
physiologic concentrations released by VSMC could have similar
effects on endothelial cell gene expression. We first examined
whether the presence of VSMC could regulate ET-1 and PDGF-B
gene expression in adjacent endothelial cells in coculture studies.
Northern blot analysis of endothelial RNA showed that in the
absence of VSMC, ET-1 mRNA levels increased 5.8-fold by 12
hours of hypoxia and 7.2-fold by 48 hours above control levels
(Fig. 5). In contrast, ET-1 mRNA in endothelial cells cocultured
with VSMC was not induced until 24 hours of hypoxia (<2-fold)
and the maximal induction was 5.7-fold above control levels at 48
hours. These findings suggest that the factor responsible for
suppressing hypoxia-induced increases in ET-1 and PDGF-B
mRNA is produced from VSMC in the early hypoxic period and
its production decreases by 48 hours of hypoxia. Furthermore, its
effects are specific for the ET-1 and PDGF-B genes, that is, genes
regulated by hypoxia in these cells.
To examine if CO is the factor released early in the hypoxic
period that is responsible for the changes in gene expression by
endothelial cells, we inhibited CO release in two ways: by using
Hb, a scavenger of CO, or the inhibitor of HO, tin-protoporphyrin
IX (SnPP-9). Given that NO is produced by vascular cells and can
regulate gene expression, we inhibited its production by adding
L-NNA, a known inhibitor of NO synthesis, to the cultures. Under
normoxia, none of these agents affected the expression of ET-1
(Fig. 6). However, under hypoxia, although L-NNA had no effect,
SnPP and Hb reversed the effects of coculturcd VSMC on
endothclial cell gene expression, allowing for high expression of
ET-l, similar to that in endothelial cells cultured alone. Collec-
tively, these findings suggest that CU, the product of F1O, released
by hypoxic VSMC into the media, is responsible for the suppres-
sion of hypoxia-induced increases in ET-1. Identical responses
were noted with the PDGF-B gene.
The above data indicate that VSMC exposed to hypoxia for 12
hours released greater amounts of CO into the media than cells
exposed to hypoxia for 48 hours. This VSMC-derived CO sup-
pressed the production of both ET-1 and PDGF-B by endothelial
cells, Since both these factors are potent mitogens for VSMC, we
speculated that by suppressing their expression, CO could regu-
SnPP-9
PDGF/ET-Ab — — — — +
Fig. 7. VSMC-derived CO controls replication of VSMC via ET-1 and
PDGF-BB. VSMC proliferation is determined in coculture with endothe-
hal cells under normoxia () or hypoxia (U) in the presence of SnPP-9,
anti-PDGF and ET-1 antibodies as indicated. The values are shown as
percentages of number of control VSMC in the absence of endothelial
cells at the start of coculture (N = 6) (mean SEM) P < 0.05, ***J) <
0.001 versus control.
late VSMC proliferation rate in an indirect manner. Indeed, this
is demonstrated on Figure 7. Proliferation of VSMC was deter-
mined in the presence of endothelial cells under normoxia or
hypoxia. The presence of endothelial cells resulted in a modest
increase of VSMC number by 24 hours under either normoxia or
hypoxia. When CO production was inhibited with SnPP-9, there
was no change in smooth muscle cell number under normoxia;
however, there was a threefold rise in VSMC number under
hypoxia. To determine if this increase in smooth muscle cell
proliferation was due to the increased production of PDGF
and/or ET-1, antibodies to these mitogens were added to the
cultures. Anti-PDGF and ET-1 antibodies reversed the prolifer-
ative response of VSMC markedly to control levels of cells
cultured under normoxia. These findings confirm that CO indeed
can regulate smooth muscle cell growth via the production of
ET-1 and PDGF in adjacent endothelial cells.
We speculate that, in the normal vasculature, the basal produc-
tion of CO may be lower than NO. Unlike NO, CO is a less potent
vasodilator than NO and may not be the predominant regulator of
vessel integrity under basal conditions. However, once the pro-
duction of NO in endothehial cells is impaired for any reason, such
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as hypoxia, VSMC-derived CO may take over as an important
regulator of gene expression and cGMP levels in vascular endo-
thelial and smooth muscle cells. In this manner, the CO produced
by VSMC may play an important physiologic role in regulating
endothelial-smooth muscle cell interactions and modulating blood
vessel tone in response to hypoxia.
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